Total Artificial Heart Implantation Blood Pressure Management as Resolving Treatment for Massive Hemolysis following Total Artificial Heart Implantation

Authors

  • Ali Ghodsizad Division of Thoracic Transplantation and MCS, Miami Transplant Institute, University of Miami, Jackson Memoral Hospital, Miami, Flordia and Heart and Vascular Institute, Pennstate Milton Hershey Medical Center, Penn State College of Medicine, Hershey Pennsylvania
  • Michael M. Koerner Department of MCS, Integris Health Nazi Zuhdi Transplant and Advanced Cardiac Institute, Oklahoma City, Oklahoma
  • A El-Banayosy Department of MCS, Integris Health Nazi Zuhdi Transplant and Advanced Cardiac Institute, Oklahoma City, Oklahoma
  • Mohamed Zeriouh Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Harefield
  • Arjang Ruhparwar Department of Cardiac Surgery, University of Heidelberg
  • Matthias Loebe Heart and Vascular Institute, Pennstate Milton Hershey Medical Center, Penn State College of Medicine, Hershey Pennsylvania

DOI:

https://doi.org/10.1532/hsf.1633

Abstract

The SynCardia Total Artificial Heart (TAH) has been used for patients with biventricular failure, who cannot be managed with implantation of a left ventricular (LV) assist device. Following TAH implantation, our patient developed severe hemolysis, which could only be managed successfully by aggressive blood pressure control [Ohashi 2003; Nakata 1998].

References

Nakata Ki, Ohashi Y, Muller J, Gleuck J, Nose Y. 1998. Assessment of the total artificial heart (TAH) pulsatility: the coalition between pulsatility and ejection time in TAH in vitro study. Ann Thorac Cardiovasc Surg 4:275-9.

Ohashi Y, de Andrade A, Nosé Y. 2003. Hemolysis in an electromechanical driven pulsatile total artificial heart. Artif Organs 27:1089-93.

Published

2016-10-21

How to Cite

Ghodsizad, A., Koerner, M. M., El-Banayosy, A., Zeriouh, M., Ruhparwar, A., & Loebe, M. (2016). Total Artificial Heart Implantation Blood Pressure Management as Resolving Treatment for Massive Hemolysis following Total Artificial Heart Implantation. The Heart Surgery Forum, 19(5), E229. https://doi.org/10.1532/hsf.1633

Issue

Vol. 19 No. 5 (2016)

Section

Article
Author Disclosure & Copyright Agreement